Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 27, 2018 - Issue 3
Submit an article Journal homepage
1,929
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluation

Inclisiran for the treatment of dyslipidemia

Toshiyuki NishikidoImperial Centre for Cardiovascular Disease Prevention (ICCP), Department of Primary Care and Public Health, School of Public Health, Imperial College London, UK;Department of cardiovascular medicine, Saga University, Saga, JapanCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3306-281XView further author information
ORCID Icon &
Kausik K. RayImperial Centre for Cardiovascular Disease Prevention (ICCP), Department of Primary Care and Public Health, School of Public Health, Imperial College London, UKView further author information
Pages 287-294 | Received 18 Nov 2017, Accepted 14 Feb 2018, Published online: 22 Feb 2018

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Yajnavalka Banerjee, Anca Pantea Stoian, Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Dragana Nikolic, Alexandros Sachinidis, Ali A. Rizvi, Andrej Janez & Manfredi Rizzo. (2022) Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia. Expert Opinion on Drug Safety 21:1, pages 9-20.
Read now
Brian Tomlinson, Nivritti Gajanan Patil, Manson Fok & Christopher Wai Kei Lam. (2021) Managing dyslipidemia in patients with Type 2 diabetes. Expert Opinion on Pharmacotherapy 22:16, pages 2221-2234.
Read now
Brian Tomlinson, Paul Chan, Yuzhen Zhang & Christopher Wai Kei Lam. (2020) Efficacy and safety of add on therapies in patients with hypercholesterolemia undergoing statin therapy. Expert Opinion on Pharmacotherapy 21:17, pages 2137-2151.
Read now
Brian Tomlinson, Paul Chan, Yuzhen Zhang, Zhongmin Liu & Christopher Wai Kei Lam. (2020) Pharmacokinetics of current and emerging treatments for hypercholesterolemia. Expert Opinion on Drug Metabolism & Toxicology 16:5, pages 371-385.
Read now
Massimiliano Ruscica, Zeljko Reiner & Cesare R. Sirtori. (2019) Can we further optimize statin therapy to increase tolerability?. Expert Opinion on Drug Discovery 14:9, pages 843-847.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.